Alkem Laboratories

Alkem Laboratories, an India-based Pharmaceutical Preparation Manufacturing company, reported its latest emissions data for 2025. In 2025, the company's Scope 1 emissions were 33,018,000 kg CO2e, and its Scope 2 emissions were 76,079,000 kg CO2e. The total Scope 1 and 2 emissions for 2025 were 109,097,000 kg CO2e.

Looking at previous years, in 2024, Alkem Laboratories disclosed Scope 1 emissions of 19,249,000 kg CO2e, Scope 2 emissions of 82,319,000 kg CO2e, and Scope 3 emissions of 365,176,000 kg CO2e. Their total Scope 1 and 2 emissions for 2024 were 101,568,000 kg CO2e. For 2023, the company reported Scope 1 emissions of 19,249,000 kg CO2e, Scope 2 emissions (both market-based and location-based) of 82,319,000 kg CO2e, and Scope 3 emissions of 365,176,000 kg CO2e, with total Scope 1 and 2 emissions reaching 101,568,000 kg CO2e.

In 2022, Alkem Laboratories’ Scope 1 emissions were 15,773,000 kg CO2e, and Scope 2 emissions were 78,502,000 kg CO2e, resulting in total Scope 1 and 2 emissions of 94,275,000 kg CO2e. In 2021, the company's Scope 1 emissions were 20,621,000 kg CO2e, and Scope 2 emissions were 94,284,000 kg CO2e, totalling 114,905,000 kg CO2e for Scope 1 and 2.

Alkem Laboratories has set a near-term target to reduce its Scope 1 and 2 greenhouse gas emissions by 42% by financial year 2033, against a 2023 baseline.